Bio/Pharma News

Agenus Collaborates with Merck for Novel Checkpoint Antibody-Based Cancer Immunotherapies

April 30, 2014

Agenus and Merck work together to advance immune-oncology programs.

Gallus BioPharmaceuticals Uses ambr15 Micro Bioreactor to Develop Novel Antibodies and Biosimilars

April 30, 2014

TAP Biosystems announced that Gallus BioPharmaceuticals is using its ambr15 micro bioreactor system to optimize process development and clone selection of novel antibody therapeutics and biosimilars.

Allergy Therapeutics' Worthing Facility Receives Certificate of GMP Compliance

April 30, 2014

Allergy Therapeutics announced that its Worthing facility has received its Certificate of GMP Compliance following recent inspection by the MHRA.

Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

April 23, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.

Novartis and GSK Trade Assets

April 22, 2014

Portfolio swaps between Novartis and GSK involve oncology, vaccines, and consumer products.

Eli Lilly's Cyramza Receives FDA Approval for Treatment of Advanced Gastric Cancer

April 22, 2014

Lilly's Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.

GSK Receives FDA Approval for Tanzeum

April 16, 2014

GSK receives FDA approval of Tanzeum for adults with type 2 diabetes.

EMA Sends Roche Findings to European Commission

April 14, 2014

EMA sends its results on Roche investigation of pharmacovigilance non-compliance to the European Commission.

PolyTherics and MacroGenics Extend ADC Collaboration

April 11, 2014

ThioBridge linker technology to attach different payloads to a range of antibodies

Takeda, Lilly to Challenge $9 Billion Verdict in Diabetes Drug Case

April 09, 2014

Takeda Pharmaceuticals and Eli Lilly announced that they plan to challenge a $9 billion judgment in a lawsuit that alleged Actos caused a patient's bladder cancer.